MaaT Pharma

OverviewSuggest Edit

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat serious diseases linked to imbalances in the intestinal microbiome. It has developed the first treatment solution based on autologous microbiotherapy. MaaT Pharma envisages a first therapeutic application for patients suffering from leukaemia and bone & joint infections, whose major treatment contributes to dysbiosis. Funded jointly by a team which brings together world-class medical-scientific and entrepreneurial skills, MaaT Pharma has the ambition of becoming a leader in microbiome protection and the treatment of dysbiosis.
TypePrivate
Founded2014
HQLyon, FR
Websitemaatpharma.com

Latest Updates

Employees (est.) (Jun 2022)50(+3%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at MaaT Pharma

Herve Affagard

Herve Affagard

Chief Executive Officer, Co Founder, Director
John Weinberg

John Weinberg

Chief Medical Officer
Jean Volatier

Jean Volatier

Non Executive Director
Siân Crouzet

Siân Crouzet

Chief Operations Officer
Savita Bernal

Savita Bernal

Chief Business Officer
Martine George

Martine George

Non Executive Director
Show more

MaaT Pharma Office Locations

MaaT Pharma has an office in Lyon
Lyon, FR (HQ)
321 Avenue Jean Jaurès
Show all (1)

MaaT Pharma Financials and Metrics

Summary Metrics

Founding Date

2014

MaaT Pharma total Funding

$32.1 m

MaaT Pharma latest funding size

$19.81 m

Time since last funding

2 years ago

MaaT Pharma investors

MaaT Pharma's latest funding round in February 2020 was reported to be $19.8 m. In total, MaaT Pharma has raised $32.1 m
Show all financial metrics

MaaT Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

MaaT Pharma Online and Social Media Presence

Embed Graph

MaaT Pharma Blogs

MaaT Pharma in the top 3 biotechs to watch – Le Revenu (Article in French)

The post MaaT Pharma in the top 3 biotechs to watch – Le Revenu (Article in French) appeared first on MaaT Pharma.

R&D Day 2022 replay

The post R&D Day 2022 replay appeared first on MaaT Pharma.

MaaT Pharma Confirms Positive Results from Completed Phase 1b CIMON Study Evaluating MaaT033 in Blood Cancer Patients

The post MaaT Pharma Confirms Positive Results from Completed Phase 1b CIMON Study Evaluating MaaT033 in Blood Cancer Patients appeared first on MaaT Pharma.

MaaT Pharma to Host First Virtual R&D Day on June 7th, 2022

The post MaaT Pharma to Host First Virtual R&D Day on June 7th, 2022 appeared first on MaaT Pharma.

MaaT Pharma Announces Combined General Meeting on May 31, 2022 and the Availability of the Preparatory Documents

The post MaaT Pharma Announces Combined General Meeting on May 31, 2022 and the Availability of the Preparatory Documents appeared first on MaaT Pharma.

MaaT Pharma Announces Resignation of an Independent Board Member

The post MaaT Pharma Announces Resignation of an Independent Board Member appeared first on MaaT Pharma.
Show more

MaaT Pharma Frequently Asked Questions

  • When was MaaT Pharma founded?

    MaaT Pharma was founded in 2014.

  • Who are MaaT Pharma key executives?

    MaaT Pharma's key executives are Herve Affagard, John Weinberg and Jean Volatier.

  • How many employees does MaaT Pharma have?

    MaaT Pharma has 50 employees.

  • Who are MaaT Pharma competitors?

    Competitors of MaaT Pharma include Harbour Antibodies, Azitra and PDC Line Pharma.

  • Where is MaaT Pharma headquarters?

    MaaT Pharma headquarters is located at 321 Avenue Jean Jaurès, Lyon.

  • Where are MaaT Pharma offices?

    MaaT Pharma has an office in Lyon.

  • How many offices does MaaT Pharma have?

    MaaT Pharma has 1 office.